Supply of Licensed Compound. Licensed Product. Licensor shall be responsible, at Licensor's expense, for supplying SPL with Licensed Compound (in the form of bulk active), from Licensor's existing inventory of Licensed Compound, to enable SPL to perform [ * ]. In addition, Licensor has the limited option to supply all of SPL's requirements of Licensed Products as set forth in Section 3.3(b). All Licensed Compound to be supplied by Licensor hereunder shall be delivered FCA (Kenilworth, New Jersey) (Incoterms 1990) via a carrier to be specified by SPL. Licensor warrants and represents that all supplies of Licensed Compound provided to SPL by Licensor shall conform to the applicable specifications for such Licensed Compound and were prepared in accordance with current Good Manufacturing Practices ("cGMPs") and other applicable federal, national, state and local laws and regulations in effect at the time of manufacture. SPL shall be responsible for the formulation and packaging of the Licensed Compound provided by Licensor hereunder, and for manufacture and supply of all Licensed Compound and/or Licensed Product necessary for the performance of [ * ] and for supplying all commercial quantities of Licensed Compound and Licensed Products. Licensor shall transfer to SPL all Licensor Know-How relating to the manufacture of Licensed Compound, and at SPL's request and expense shall provide reasonable technical support to facilitate the implementation of such manufacturing technology at SPL.
Appears in 3 contracts
Samples: Exclusive License Agreement (Atherogenics Inc), Exclusive License Agreement (Atherogenics Inc), Exclusive License Agreement (Atherogenics Inc)
Supply of Licensed Compound. Licensed Product. Licensor shall be responsible, at Licensor's expense, for supplying SPL Schering with Licensed Compound (in the form of bulk active), from Licensor's existing inventory of Licensed Compound, to enable SPL Schering to perform [ * ], for such Licensed Compound for the Primary Indication. In addition, Licensor has the limited option to supply all of SPLSchering's requirements of Licensed Products as set forth in Section 3.3(b). All Licensed Compound to be supplied by Licensor hereunder shall be delivered FCA (Kenilworth, New Jersey) (Incoterms 1990) via a carrier to be specified by SPLSchering. Licensor warrants and represents that all supplies of Licensed Compound provided to SPL Schering by Licensor shall conform to the applicable specifications for such Licensed Compound and were prepared in accordance with current Good Manufacturing Practices ("cGMPs") and other applicable federal, national, state and local laws and regulations in effect at the time of manufacture. SPL Schering shall be responsible for the formulation and packaging of the Licensed Compound provided by Licensor hereunder, and for manufacture and supply of all Licensed Compound and/or Licensed Product necessary for the performance of [ * ] and for supplying all commercial quantities of Licensed Compound and Licensed Products. Licensor shall transfer to SPL Schering all Licensor Know-How relating to the manufacture of Licensed Compound, and at SPLSchering's request and expense shall provide reasonable technical support to facilitate the implementation of such manufacturing technology at SPLSchering.
Appears in 3 contracts
Samples: Exclusive License Agreement (Atherogenics Inc), Exclusive License Agreement (Atherogenics Inc), Exclusive License Agreement (Atherogenics Inc)